Finding out where certain medicines are provided and comparing prices of those medicines is unnecessarily hard in Zimbabwe. Something has to be done. That’s why The Medical Information Service -The MIS – exists.

The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20 ... 18, jumping ten places to fifth Download the full report from (Large File 22 MB) https://accesstomedicinefoundation.org/media/uploads/downloads/5c8bc9ceb714b_Access%20to%20Medicine%20Index%202018.pdf more

Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition